A PHASE II LYSA STUDY OF OBINUTUZUMAB COMBINED WITH LENALIDOMIDE FOR RELAPSED OR REFRACTORY FOLLICULAR B-CELL LYMPHOMA
| Autor: | Roch Houot, E. Van Den Neste, Luc Xerri, A. Van Hoof, Christophe Bonnet, S. Le Gouill, Franck Morschhauser, B. Fabiani, Guillaume Cartron, R. Bouabdallah, P. Feugier, K. Van Eygen, H. Tilly, E. Nicolas-Virelizier, F. Bijou, Corinne Haioun, Gilles Salles |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Cancer Research business.industry Hematology General Medicine medicine.disease Lymphoma 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine Oncology chemistry Refractory Obinutuzumab 030220 oncology & carcinogenesis medicine Cancer research Follicular B cell business Lenalidomide medicine.drug |
| Zdroj: | Hematological Oncology. 35:52-53 |
| ISSN: | 0278-0232 |
| DOI: | 10.1002/hon.2437_36 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text